The financials
Wave Life Sciences Ltd. by the numbers
Wave Life Sciences Ltd. (WVE) reported revenue of $38M in Q1 2026 (quarter ended Mar 31, 2026), up 317% from the same quarter a year earlier. That came with net loss of $26M. For the full year FY2025, revenue was $43M (−61% year on year) and net income −$204M.
| Income statement | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $38M | $9.2M | +317% |
| Operating income | −$31M | −$50M | n/a |
| Net income | −$26M | −$47M | n/a |
| Diluted EPS | −$0.13 | −$0.29 | n/a |
Business Segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Q4 2024Total $70.1M (+23267%)
Category One Programs grew +594% year on year
Segment Latestquarter on quarteryear on year
- Category One Programs$70.1M$70.1MQoQ +23267%year on year +594%+23267%+594%